Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 23;8(1):e019060.
doi: 10.1136/bmjopen-2017-019060.

Resource utilisation and costs in predementia and dementia: a systematic review protocol

Filipa Landeiro  1 , Helena Wace  1 , Isaac Ghinai  1 , Elsbeth Nye  1 , Seher Mughal  1 , Katie Walsh  1 , Nia Roberts  2 , Pascal Lecomte  3 , Raphael Wittenberg  4 , Jane Wolstenholme  1 , Ron Handels  5   6 , Emilse Roncancio-Diaz  7 , Michele H Potashman  8 , Antje Tockhorn-Heidenreich  9 , Alastair M Gray  1 ; ROADMAP Group
Affiliations

Resource utilisation and costs in predementia and dementia: a systematic review protocol

Filipa Landeiro et al. BMJ Open. .

Abstract

Introduction: Dementia is the fastest growing major cause of disability globally with a mounting social and financial impact for patients and their families but also to health and social care systems. This review aims to systematically synthesise evidence on the utilisation of resources and costs incurred by patients and their caregivers and by health and social care services across the full spectrum of dementia, from its preceding preclinical stage to end of life. The main drivers of resources used and costs will also be identified.

Methods and analysis: A systematic literature review was conducted in MEDLINE, EMBASE, CDSR, CENTRAL, DARE, EconLit, CEA Registry, TRIP, NHS EED, SCI, RePEc and OpenGrey between January 2000 and beginning of May 2017. Two reviewers will independently assess each study for inclusion and disagreements will be resolved by a third reviewer. Data will be extracted using a predefined data extraction form following best practice. Study quality will be assessed with the Effective Public Health Practice Project quality assessment tool. The reporting of costing methodology will be assessed using the British Medical Journal checklist. A narrative synthesis of all studies will be presented for resources used and costs incurred, by level of disease severity when available. If feasible, the data will be synthesised using appropriate statistical techniques.

Ethics and dissemination: Included articles will be reviewed for an ethics statement. The findings of the review will be disseminated in a related peer-reviewed journal and presented at conferences. They will also contribute to the work developed in the Real World Outcomes across the Alzheimer's disease spectrum for better care: multi-modal data access platform (ROADMAP).

Trial registration number: CRD42017071413.

Keywords: Alzheimer’s disease; costs; dementia; resources; systematic review.

PubMed Disclaimer

Conflict of interest statement

Competing interests: This SLR is being conducted as part of the ROADMAP project. ROADMAP is a consortium of academic, public sector and industry partners working collaboratively within the European Union Innovative Medicines Initiative framework. FL, HW, IG, EN, SM, KW, NR, RW, JW and AMG declare that they have no competing interests. PL is employed by, owns stock in and has stock options in Novartis Pharma AG. ERD is employed by GE Healthcare. MP is an employee of Biogen and owns stock in Biogen. She owns stock in a variety of companies that at times include other pharmaceutical and health care-related companies. ATH is an employee of Eli Lilly and Company Limited and owns stock in Eli Lilly and Company Limited. Novartis Pharma AG, GE Healthcare, Biogen and Eli Lilly and Company Limited are industry partners in the ROADMAP Project.

References

    1. OECD. Addressing Dementia: OECD Publishing.
    1. Prince M, Comas-Herrera A, Knapp M, et al. . World Alzheimer report 2016: improving healthcare for people living with dementia: coverage quality and costs now and in the future, 2016.
    1. Wimo A, Guerchet M, Ali GC, et al. . The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement 2017;13:1–7. 10.1016/j.jalz.2016.07.150 - DOI - PMC - PubMed
    1. Prince MJ, Wimo A, Guerchet MM, et al. . World Alzheimer Report 2015 - The Global Impact of Dementia: Alzheimer’s Disease International, 2015.
    1. World Health Organization. Neurological disorders: public health challenges: World Health Organization, 2006.

Publication types

LinkOut - more resources